✦ LIBER ✦

155. Tumor Necrosis In Vivo Caused by a Novel Combination of Sorafenib and Rapamycin: Targeting the RAS and Motor Pathways ION Hepatocellular Carcinoma

✍ Scribed by Pippa H. Newell; Augusto Villanueva; Judit Peix; Stijn van Laarhoven; Isabel Fiel; Swan Thung; Yea Steven; Sasan Roayaie; Myron Schwartz; Scott Friedman; Josep Llovet

Book ID: 116703722
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 148 KB
Volume: 144
Category: Article
ISSN: 0022-4804
DOI: 10.1016/j.jss.2007.12.176

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ras pathway activation in hepatocellular

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

✍ Pippa Newell; Sara Toffanin; Augusto Villanueva; Derek Y. Chiang; Beatriz Mingue 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 531 KB

Activation of Ras/MAPK and mTOR pathways

Activation of Ras/MAPK and mTOR pathways in hepatocellular carcinoma: Tumor growth inhibition with Ras/mTOR pathway abrogation by a novel combination of Sorafenib and rapamycin

✍ Philippa H. Newell; Augusto Villanueva; Judit Peix; Isabel Fiel; Swan Thung; Ste 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB